Trypsin inhibits lipopolysaccharide signaling in macrophages via toll-like receptor 4 accessory molecules

Hiroyuki Komatsu1, Akihiro Shimose, Takashi Shimizu

  • 1Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Japan.

Life Sciences
|July 10, 2012
PubMed
Abstract

Insights

Trypsin inhibits lipopolysaccharide (LPS) immune responses in macrophages by degrading CD14, independent of protease-activated receptors (PARs). This finding clarifies trypsin's role in the immune response, particularly in acute pancreatitis.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Macrophages play a crucial role in the innate immune response.
  • Lipopolysaccharide (LPS) is a potent activator of macrophages via Toll-like receptor 4 (TLR4) complex.
  • Protease-activated receptors (PARs) are involved in various cellular processes, including inflammation.

Purpose of the Study:

  • To investigate the role of trypsin in macrophage immune responses.
  • To determine if protease-activated receptors (PARs) mediate trypsin's effects on macrophages.
  • To elucidate the mechanism by which trypsin influences LPS signaling.

Main Methods:

  • Utilized RAW264.7 cells and primary macrophages from wild-type and PAR2 knockout mice.
  • Stimulated macrophages with LPS, trypsin, thrombin, and PAR-specific agonists.
  • Quantified macrophage activation via nitric oxide production and inflammatory mediator expression (iNOS, IL-1β, IL-6).
  • Assessed the expression of TLR4 and its accessory molecules (MD-2, CD14).
  • Investigated trypsin's direct effect on recombinant CD14 protein.

Main Results:

  • Trypsin significantly inhibited LPS-induced nitric oxide production and inflammatory mediator expression.
  • These inhibitory effects were observed in both wild-type and PAR2 knockout macrophages, indicating a PAR-independent mechanism.
  • Trypsin decreased the expression of soluble CD14 (sCD14), membrane-bound CD14 (mCD14), and soluble MD-2 (sMD-2).
  • Trypsin directly degraded recombinant CD14 protein.
  • Other PAR agonists did not replicate trypsin's inhibitory effects.

Conclusions:

  • Trypsin inhibits LPS signaling in a PAR-independent manner.
  • The mechanism involves the degradation of TLR4 accessory molecules, specifically CD14.
  • This study enhances understanding of the complex immune responses in conditions like acute pancreatitis.

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...